Rankings
▼
Calendar
MESO Q3 2022 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+5.1% YoY
Gross Profit
-$12M
-588.2% margin
Operating Income
-$19M
-961.7% margin
Net Income
-$21M
-1059.3% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
-15.6%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$682M
Total Liabilities
$165M
Stockholders' Equity
$517M
Cash & Equivalents
$76M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+5.1%
Gross Profit
-$12M
-$18M
+33.8%
Operating Income
-$19M
-$26M
+25.3%
Net Income
-$21M
-$27M
+19.7%
← FY 2022
All Quarters
Q4 2022 →